| Sources | Names Used |
|---|---|
| CTRPv2 | 1S,3R-RSL-3 |
| PharmacoGx | 1S,3R-RSL-3 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCDC9 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | ZNF329 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | ARHGAP33 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | SLC39A6 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | NKX6-2 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | FSTL1 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | TMEM64 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | AP1M2 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | MFAP4 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | TYW3 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
